Focal segmental glomerular sclerosis in adults: Presentation, course, and response to treatment

American Journal of Kidney Diseases

Volumn 25, Issue 4, 1995, Pages 534-542

  Rydel, James J ^a   Korbet, Stephen M ^a   Borok, Raphael Z ^a   Schwartz, Melvin M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

focal segmental glomerular sclerosis; Nephrotic syndrome; treatment

Indexed keywords

CREATININE; PREDNISONE;

ADULT; ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULOSCLEROSIS; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; ORAL DRUG ADMINISTRATION; STEROID THERAPY; SURVIVAL;

ADULT; BIOPSY; CREATININE; FEMALE; GLOMERULOSCLEROSIS, FOCAL; HUMAN; MALE; NEPHROSIS; PREDNISONE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0028943743     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/0272-6386(95)90120-5     Document Type: Article

References (32)

1. Focal glomerulosclerosis: Natural history and treatment
2. Management of the nephrotic syndrome in adults
3. The primary nephrotic syndrome of childhood
4. The primary nephrotic syndrome in children Identification of patients with minimal change nephrotic syndrome from initial response to prednisone
5. Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome
6. Long-term prognosis of focal sclerosing glomerulonephritis: An analysis of 250 cases with particular regard to tubulointerstitial changes
7. Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosis
8. The prognosis of focal segmental glomerular sclerosis of adulthood
9. The long-term prognosis of patients with focal segmental glomerulosclerosis
10. Focal sclerosing glomerulopathy Risk factors of progression and optimal mode of treatment
11. Racial differences in the incidence and renal outcome of idiopathic focal segmental glomerulosclerosis in children
12. Focal segmental glomerulosclerosis with rapid decline in renal function (“malignant FSGS”)
13. Treatment of severe nephrotic syndrome with meclofenamate: An uncontrolled pilot study
14. Primary focal segmental glomerulosclerosis: Clinical course and response to therapy
15. Adult lipoid nephrosis: Clinicopathological correlations
16. Focal segmental glomerulosclerosis
17. Focal sclerosing glomerulonephropathy: A clinicopathologic study
18. Focal glomerular sclerosis: Contrasting clinical patterns in children and adults
19. Evidence suggesting under-treatment in adults with idiopathic focal segmental glomerulosclerosis
20. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults: A collaborative retrospective study
21. Primary focal segmental glomerulosclerosis: Pathology, histologic variants, and pathogenesis
22. Clinical and pathological features of membranous glomerulonephritis of systemic lupus erythematosus
23. Nonparametric estimation from incomplete observations
24. Evaluation of survival data and two new rank order statistics arising in its consideration
25. Regression models and life tables
26. Focal segmental glomerulosclerosis: A common entity in nephrotic black adults
27. Racial differences in the prevalence and presentation of glomerular disease in adults
28. Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients
29. Focal and segmental hyalinosis
30. Evaluation and correlation of clinical and histological features of focal segmental glomerulosclerosis
31. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome